Skip to main content
. 2022 Jul 26;22(4):277–287. doi: 10.17245/jdapm.2022.22.4.277

Fig. 5. Phosphorylation of NF-κB following co-treatment of WISH cells with DEX and LPS was evaluated using western blot analysis. Relative amounts of phospho-NF-κB protein were analyzed by triplicate experiments and normalized to that of NF-κB. #P < 0.05 versus control group; *P < 0.05, **P < 0.01 versus LPS group. DEX, dexmedetomidine; LPS, lipopolysaccharide; NF-κB, nuclear factor kappa B.

Fig. 5